Delivery Order SPE2DB22D3501-SPE2DB25FVR85
Award Date
5/15/25
Potential Completion Date
5/16/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,491.74 and an ultimate completion date of March 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,758.26, is for the delivery of Entecavir 0.5 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide ENTECAVIR 0.5 MG TABLET 30S. The contract is valued at $1,087.81 and has a completion date of February 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,600.99 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a generic prescription medication. The award has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price valued at $5,709.07. The award, placed by the Defense Logistics Agency (DLA), is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The order has a ceiling value of $6,918.52 and a completion date of August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC1D3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,440.42 firm fixed-price delivery order is for the supply of 4568140358 ! ENTECAVIR 0.5 MG TABLET 30S, with a performance period through May 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $5,405.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567140392 ENTECAVIR 0.5 MG TABLET 30S to support federal government healthcare programs. The contract is not designated with a set-aside and represents an open competition award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.10 firm fixed-price contract is for the delivery of Entecavir 0.5 mg tablets. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,062.15 contract is for the delivery of Entecavir 0.5 milligram tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...